Médicos en Pekín, China — Página 3

Dr. Huang Liuming is a specialist at the clinic and a chief physician at Beijing Jingdu Children’s Hospital. He focuses on minimally invasive pediatric surgery and pediatric liver transplantation, with nearly 30 years of experience since around 1995. His differentiator is that around 2005 he led development of minimally invasive treatment for pediatric surgery and pediatric liver transplantation in China, supported by advanced training at the University of Innsbruck and Queen Mary Hospital (University of Hong Kong).

Dr. Jin Xiaoju is a specialist at the clinic and focuses on complex cleft lip and palate surgery. Her team has performed over 3,000 cleft repair surgeries with a 99.6% success rate, and her profile describes 20 years of experience across unilateral cleft lip, bilateral cleft lip, and complex alveolar cleft/palate cases. A key differentiator is the team’s emphasis on both function (feeding and speech) and appearance, with transparent cost breakdowns and early emergency repair when needed.

Dr. Li Long is a specialist at the clinic with over 30 years dedicated to pediatric surgery. He is Director of General (Neonatal) Surgery at the Children’s Hospital Affiliated to the Capital Institute of Pediatrics and Director of Pediatric Surgery at Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital. His differentiator is minimally invasive pediatric surgical expertise for congenital digestive tract malformations, including choledochal cyst, with patient-described laparoscopic outcomes and quick recovery.

Dr. Liang Tianwei is a specialist at the clinic and Director of the Ophthalmology Department at Beijing Jingdu Children’s Hospital. She has over 25 years of pediatric ophthalmology experience since starting clinical practice in 1998, including systematic treatment leadership for pediatric glaucoma, cataracts, and fundus diseases. Her differentiator includes extensive infant cataract experience (over 1,000 surgeries) and strabismus treatment using modified botulinum toxin injection therapy for congenital esotropia, paired with amblyopia training.

Dr. Liu Hongyan is a specialist at the clinic and an Associate Chief Physician in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. She has 15 years of clinical experience focused on childhood blood disorders and cancers. Her differentiator is clinical recognition—she received an Outstanding Physician Award at the former Beijing Armed Police General Hospital’s Pediatric Department—and her training includes a Master’s in Pediatrics from Guangxi Medical University (2010).

Dr. Shen Gang is a specialist at the clinic and Director of the Interventional Vascular Anomalies Department at Beijing JingDu Children’s Hospital. With nearly 30 years of experience, he has personally performed or participated in over 50,000 interventional surgeries and sees more than 6,000 outpatient visits annually. His differentiator is innovation and training leadership: he founded China’s first vascular anomalies and interventional vascular center, pioneered a national pediatric training base, and advanced techniques including a 0.53mm ultra-microcatheter (patent ZL201080005678.9) and 4D-DSA + AI for optimal embolization path planning.

Dr. Wu Minyuan is a specialist at the clinic and a Professor/Chief Physician/Doctoral Supervisor in pediatric hematology at Beijing Jingdu Children’s Hospital. She has over 50 years of clinical and academic leadership and is described as a pioneer in childhood leukemia treatment. Her differentiator is protocol leadership: as former Director of the Hematology Center at Beijing Children’s Hospital, she spearheaded national protocols that raised 5-year disease-free survival for pediatric ALL to over 80%, alongside work on risk-stratified chemotherapy and multi-center trials integrating chemotherapy, immunotherapy, and targeted therapies.

Dr. Wu Nanhai is a specialist at the clinic and holds leadership roles as Deputy Director of the Hematology and Oncology Center and Director of Ward 9 at Beijing Jingdu Children’s Hospital. He has nearly 40 years of clinical and academic leadership experience, including early work as Deputy Director of Pediatrics at the Sixth Medical Center of the PLA General Hospital (formerly the Navy General Hospital). His differentiator is combined clinical leadership and academic influence, including Executive Deputy Editor-in-Chief of Chinese Journal of Pediatric Blood and Oncology and membership in major pediatric oncology/hematology professional groups.

Dr. Chou Xiaobing is a specialist at the clinic and Director of Pediatric Orthopedics at Beijing Jingdu Children’s Hospital. He has over 15 years of experience, including more than 50,000 outpatient and emergency visits and over 4,000 pediatric orthopedic surgeries over the past 10 years. His differentiator is minimally invasive ESIN care: a “closed reduction + ESIN fixation” protocol with incision lengths under 2 cm in 100% of his 92 ESIN cases and a 95% satisfactory reduction rate. He also collaborated with Tsinghua University on an AI preoperative planning system for needle insertion pathways and callus growth prediction.

Dr. Xiao Juan is a specialist at the clinic and Chief Physician/Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. With nearly 20 years of clinical experience, she focuses on HSCT and cellular immunotherapy for refractory childhood blood diseases, including refractory acute B lymphoblastic leukemia. Her differentiator includes academic recognition—an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for refractory acute B lymphoblastic leukemia in children.